Oxygen4Life

About the offering

Chronic disease is a $4.5[1] trillion problem killing millions every year. The U.S. healthcare system waits for people to get sick before doing anything. Only 1% [2] of healthcare spending goes to prevention. Patients are done waiting—they’re spending their own money on early detection and real solutions. That’s why AI in medical imaging is exploding—from $1B to $15.3B by 2032[3]. Infrared imaging in healthcare? Doubling from $6.75B to $12.78B by 2031[4]. Oxygen4Life isn’t following the trend—we’re leading it. Are you ready? Keep reading. The Problem: Healthcare is Reactive, Not Proactive 70% of deaths in the U.S. are linked to chronic inflammatory diseases like heart disease, neuropathy, and diabetes.[5] The current diagnostic system only detects problems once symptoms are severe, leaving millions untreated. The U.S. spends $4 trillion annually on chronic disease care—but most solutions treat symptoms, not the root cause. There has to be a better way... Oxygen4Life, Inc. IS that way... The Future of Healing is Here, and It’s Already Changing Lives What if millions of deaths from chronic inflammation, neuropathy, and cardiovascular disease could be prevented? What if medicine wasn’t just about treating symptoms—but actually detecting problems early enough to reverse damage before it’s too late? What if healing wasn’t just reactive—but proactive, AI-driven, and personalized? That future isn’t decades away. It’s happening NOW. For the millions suffering from chronic inflammation, a silent killer that underlies conditions like diabetes, heart disease, and neurodegeneration… For veterans and first responders struggling with PTSD and TBI, forced to navigate a healthcare system that reacts too late… For diabetic patients at risk of neuropathy and foot ulcers, facing life-altering amputations… For the millions unknowingly walking around with vascular disease, with no way of detecting it until a major event like a heart attack or stroke strikes... There is a better way. And it’s already here! A Shift is Happening and It’s Moving Faster Than Ever. AI is revolutionizing diagnostics. The market for AI in medical imaging is skyrocketing—from $1B to $14.4B by 2032.[3] Infrared imaging in healthcare is becoming a world wide standard. Expected to nearly double from $6.75B to $12.78B by 2031.[4] Preventative medicine is no longer optional. Consumers are tired of reactive healthcare and are investing in solutions that detect disease before it happens. The healthcare industry is transforming. The investors who recognize this shift early are the ones who win. And at the center of this transformation? Oxygen4Life. Not just another biotech company. Not a supplement. Not another drug. Not just a diagnostic tool. FDA-cleared, AI-powered system for early detection AND management of chronic inflammation and disease. The Investment Opportunity: A Rare Chance to Get in Early on the Future of Healthcare Imagine a world where chronic diseases like neuropathy, cardiovascular disease, and others are detected before they spiral out of control. Where patients no longer have to wait until they’re sick to get answers. Where AI, infrared imaging, and science-backed inflammation management combine to redefine preventative healthcare—saving millions of lives and billions in healthcare costs. Now, imagine being able to invest in that future before the rest of the world catches on. Oxygen4Life is not a concept. It’s happening now. FDA-cleared technology is already in use Proprietary AI-driven database with over 1,000,000 medical images A patented medical food designed for inflammation management A physician training platform accelerating adoption across clinics, hospitals, and practitioners worldwide Moments like these are rare for investors. Just think about it: Think about the early investors in most industries, they were positioned for the biggest growth. What was the difference between those who made life-changing returns and those who didn’t? TIMING! The Market Size of Chronic Inflammatory Diseases Chronic inflammatory diseases like heart disease, diabetes, and neurodegenerative disorders account for 70% of deaths in the U.S., contributing to a $4 trillion healthcare burden. Diabetes-related complications cost the U.S. healthcare system $327 billion annually, with Diabetic Peripheral Neuropathy (DPN) alone ranging from $4.6B to $13.7B per year.[6] PTSD & Traumatic Brain Injury (TBI) impact millions of veterans and first responders, with over $100 billion spent annually on treatment and disability costs.[7] Vascular diseases such as stroke, peripheral artery disease, and cardiovascular disorders contribute to 1 in 3 deaths globally, with an estimated economic impact of $363 billion annually.[8] Chronic wounds and diabetic foot ulcers (DFUs) represent a $28B–$31.7B healthcare challenge, leading to over 80,000 amputations per year in the U.S. alone.[9] Neurodegenerative diseases like Alzheimer’s cost the U.S. over $345 billion per year, with projections reaching $1 trillion by 2050.[11] Autoimmune diseases, including conditions like rheumatoid arthritis and lupus, impact over 24 million Americans, with total healthcare spending exceeding $100 billion annually.[12] Inflammation is the silent killer behind all of these diseases. Diseases that cripple lives, and are draining trillions from the healthcare system. The Solution: AI-Driven Diagnostics + Proven Treatments Oxygen4Life, Inc. combines FDA-cleared medical imaging, AI diagnostics, and patented therapeutic solutions to detect, track, and manage chronic diseases before they escalate. Fix the inflammation problem and you change everything. Cut billions in wasted healthcare costs Improve patient outcomes—helping people live longer, healthier, and more functional lives Empower medical practitioners to keep more revenue in-house while delivering better care The system is broken. The cost is staggering. The opportunity to fix it is here. This Is Not a "What If" Scenario, It’s Happening NOW. This isn’t a theory. It isn’t a future concept. It’s already in motion. Our Game-Changing Product-Line: 1. ThermaLens™ IRIS-XP - Infrared Imaging System FDA Cleared - Medical Infrared Imaging System ThermaLens™ IRIS-XP is non-invasive, FDA-cleared and ready for immediate use by physicians, clinics, and government healthcare providers. Unlike competitors still in clinical trials, our technology is already in the hands of practitioners. It combines a high-resolution, infrared camera, with a proprietary artificial intelligence software for fast, accurate, and automatic disease detection. This system can precisely measures a patient's heat signature to within a fraction of a degree, then use machine learning to cross-reference this data with our extensive database of verified medical cases.[13] This enables for the early detection of conditions such as: Diabetic foot ulcers, breast cancer, circulatory diseases, neuropathy, chronic inflammation, peripheral artery disease, and more. 2. AiLLUMI™ - AI Powered Diagnostics AiLLUMI™: The AI-Powered Diagnostic Breakthrough that transforms lives. A proprietary database of over 1,000,000 infrared medical images—making it one of the largest AI-driven thermal imaging datasets in the world. Provides instant, data-backed diagnostic insights to help medical professionals detect inflammation, vascular disease, neuropathy, PTSD, and more—before symptoms escalate. Continuously learning and evolving—every new scan refines the system’s accuracy, ensuring practitioners get the most precise, real-time analysis possible. Bridges the gap between AI and clinical decision-making, allowing faster, more accurate diagnoses and better patient outcomes. With AiLLUMI™, practitioners don’t just see the problem—they understand it, predict it, and act before it’s too late. Comprehensive care doesn't stop with early detection Addressing the underlying conditions is equally as important. 3. Brivanta™ - Patented Organic Medical Food Brivanta™ is a plant-based, cold-pressed, and organic Essential Fatty Acid formulation, specifically designed as a medical food for those with an impaired Delta-6 Desaturase Enzymatic Pathway. As we age, the Delta-6 Desaturase enzymatic pathway is known to become impaired.⁷ This impairment has been linked to multiple chronic inflammatory diseases and immune-deficiencies. With over two decades in development, Brivanta™ offers a targeted dietary management approach for chronic inflammation. Today, the modern diet unknowingly may cause chronic inflammation leading to ill-health.[14][15] Inflammatory response starts with the Delta-6 Desaturase enzymatic pathway.[16] Targeted Relief: Provides relief to those battling chronic inflammatory diseases due to a Delta-6 Desaturase Pathway impairment. Physician Supervised: This medical food is exclusively available under the guidance of a licensed physician. Patented & Proven: Patents granted in the United States and Canada, backed by over 20 years of evidence-based research and development. Easy Administration: Brivanta™, is an oil that remains liquid even at cold temperatures, and should be stored in the fridge to prevent rancidity. It comes with a small measuring spoon for easy and precise dosing. Brivanta™ falls under the orphan drug act and is only available through a licensed MD. How Does Brivanta™ Work? What Diseases, Disorders, and Impairments Does Brivanta™ manage? • Diabetes (Type 1 & Type 2) including Neuropathy • Lipid-Enveloped Viruses (including COVID series) • Alzheimer’s • Dermatological Conditions • Cardiovascular Disease • Inflammatory Bowel Disease • Chronic Fatigue (including post viral syndromes) • Fatty Liver Disease Including NAFLD • Cancer • Arthritis • Multiple Sclerosis Respiratory Diseases Related with Chronic Inflammation: • Mesothelioma • Idiopathic Pulmonary Fibrosis (IPF) • Chronic Obstructive Pulmonary Disease (COPD) Brivanta™ helps facilitate the production of eicosanoids, important signaling molecules for the body, as shown below What Is A Medical Food? "The term medical food, as defined in section 5(b) of the Orphan Drug Act (21 U.S.C. 360ee (b) (3)) is "a food which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation." Manufacturers of medical foods must comply with all applicable FDA requirements for foods, including the following regulations: • Current good manufacturing practice (21 CFR part 110); • Registration of food facilities (21 CFR part 1 subpart H);

FAQ